Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.43 |
| ▸ | CKS1B | P61024 | 1/20 | 0.40 |
| ▸ | SKP1 | P63208 | 1/20 | 0.40 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15586613 | 0.89 | NQO2 (0.44) | NQO2CTSSCTSKCKS1BSKP1 | |
| SCHEMBL2119195 | 0.81 | CKS1B (0.45) | NQO2CKS1BSKP1SKP2DRD2 | |
| SCHEMBL17013849 | 0.78 | CTSS (0.38) | CTSSCTSK | |
| SCHEMBL8536367 | 0.77 | CTSS (0.45) | NQO2CTSSCTSKNR1D1CKS1B | |
| SCHEMBL2121412 | 0.77 | APP (0.45) | CKS1BSKP1SKP2DRD2 | |
| SCHEMBL1579453 | 0.77 | NQO2 (0.75) | NQO2CTSSCTSKMTNR1AKDM4A | |
| SCHEMBL17013843 | 0.77 | CYP2D6 (0.50) | DRD2ATMBCHE | |
| SCHEMBL12373442 | 0.76 | CYP2D6 (0.56) | DRD2ATM | |
| SCHEMBL6033875 | 0.76 | NQO2 (0.55) | NQO2CTSKDRD2BCHE | |
| SCHEMBL10243147 | 0.75 | CDYL (0.49) | MTNR1AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10017525-B2 | Multi-sensor array compound and methods of use thereof | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-07-10 | — | — | US | disclosed |
| US-20150232485-A1 | MULTI-SENSOR ARRAY COMPOUND AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10017525-B2 | Multi-sensor array compound and methods of use thereof | GPR119, CA12, INSR | NQO2 2743/4885CTSS 2696/4885CTSK 2883/4885 |
| US-20150232485-A1 | MULTI-SENSOR ARRAY COMPOUND AND METHODS OF USE THEREOF | GPR119, CA12, INSR | NQO2 2743/4885CTSS 2696/4885CTSK 2883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.